journal
MENU ▼
Read by QxMD icon Read
search

Nature Reviews. Cancer

journal
https://www.readbyqxmd.com/read/28184043/early-detection-the-algorithm-will-see-you-now
#1
Anna Dart
No abstract text is available yet for this article.
February 10, 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/28184042/tumorigenesis-fitness-penalties-of-aneuploidy
#2
Sarah Seton-Rogers
No abstract text is available yet for this article.
February 10, 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/28154375/notch-as-a-tumour-suppressor
#3
REVIEW
Craig S Nowell, Freddy Radtke
The Notch signalling cascade is an evolutionarily conserved pathway that has a crucial role in regulating development and homeostasis in various tissues. The cellular processes and events that it controls are diverse, and continued investigation over recent decades has revealed how the role of Notch signalling is multifaceted and highly context dependent. Consistent with the far-reaching impact that Notch has on development and homeostasis, aberrant activity of the pathway is also linked to the initiation and progression of several malignancies, and Notch can in fact be either oncogenic or tumour suppressive depending on the tissue and cellular context...
February 3, 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/28154374/precision-diagnostics-moving-towards-protein-biomarker-signatures-of-clinical-utility-in-cancer
#4
REVIEW
Carl A K Borrebaeck
Interest in precision diagnostics has been fuelled by the concept that early detection of cancer would benefit patients; that is, if detected early, more tumours should be resectable and treatment more efficacious. Serum contains massive amounts of potentially diagnostic information, and affinity proteomics has risen as an accurate approach to decipher this, to generate actionable information that should result in more precise and evidence-based options to manage cancer. To achieve this, we need to move from single to multiplex biomarkers, a so-called signature, that can provide significantly increased diagnostic accuracy...
February 3, 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/28134258/sumo-and-the-robustness-of-cancer
#5
REVIEW
Jacob-Sebastian Seeler, Anne Dejean
Post-translational protein modification by small ubiquitin-like modifier (SUMO), termed sumoylation, is an important mechanism in cellular responses to stress and one that appears to be upregulated in many cancers. Here, we examine the role of sumoylation in tumorigenesis as a possibly necessary safeguard that protects the stability and functionality of otherwise easily misregulated gene expression programmes and signalling pathways of cancer cells.
30, 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/28104906/interrogating-open-issues-in-cancer-precision-medicine-with-patient-derived-xenografts
#6
REVIEW
Annette T Byrne, Denis G Alférez, Frédéric Amant, Daniela Annibali, Joaquín Arribas, Andrew V Biankin, Alejandra Bruna, Eva Budinská, Carlos Caldas, David K Chang, Robert B Clarke, Hans Clevers, George Coukos, Virginie Dangles-Marie, S Gail Eckhardt, Eva Gonzalez-Suarez, Els Hermans, Manuel Hidalgo, Monika A Jarzabek, Steven de Jong, Jos Jonkers, Kristel Kemper, Luisa Lanfrancone, Gunhild Mari Mælandsmo, Elisabetta Marangoni, Jean-Christophe Marine, Enzo Medico, Jens Henrik Norum, Héctor G Palmer, Daniel S Peeper, Pier Giuseppe Pelicci, Alejandro Piris-Gimenez, Sergio Roman-Roman, Oscar M Rueda, Joan Seoane, Violeta Serra, Laura Soucek, Dominique Vanhecke, Alberto Villanueva, Emilie Vinolo, Andrea Bertotti, Livio Trusolino
Patient-derived xenografts (PDXs) have emerged as an important platform to elucidate new treatments and biomarkers in oncology. PDX models are used to address clinically relevant questions, including the contribution of tumour heterogeneity to therapeutic responsiveness, the patterns of cancer evolutionary dynamics during tumour progression and under drug pressure, and the mechanisms of resistance to treatment. The ability of PDX models to predict clinical outcomes is being improved through mouse humanization strategies and the implementation of co-clinical trials, within which patients and PDXs reciprocally inform therapeutic decisions...
January 20, 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/28050011/consensus-molecular-subtypes-and-the-evolution-of-precision-medicine-in-colorectal-cancer
#7
Rodrigo Dienstmann, Louis Vermeulen, Justin Guinney, Scott Kopetz, Sabine Tejpar, Josep Tabernero
Critical driver genomic events in colorectal cancer have been shown to affect the response to targeted agents that were initially developed under the 'one gene, one drug' paradigm of precision medicine. Our current knowledge of the complexity of the cancer genome, clonal evolution patterns under treatment pressure and pharmacodynamic effects of target inhibition support the transition from a one gene, one drug approach to a 'multi-gene, multi-drug' model when making therapeutic decisions. Better characterization of the transcriptomic subtypes of colorectal cancer, encompassing tumour, stromal and immune components, has revealed convergent pathway dependencies that mandate a 'multi-molecular' perspective for the development of therapies to treat this disease...
February 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/27977008/the-recurrent-architecture-of-tumour-initiation-progression-and-drug-sensitivity
#8
Andrea Califano, Mariano J Alvarez
Recent studies across multiple tumour types are starting to reveal a recurrent regulatory architecture in which genomic alterations cluster upstream of functional master regulator (MR) proteins, the aberrant activity of which is both necessary and sufficient to maintain tumour cell state. These proteins form small, hyperconnected and autoregulated modules (termed tumour checkpoints) that are increasingly emerging as optimal biomarkers and therapeutic targets. Crucially, as their activity is mostly dysregulated in a post-translational manner, rather than by mutations in their corresponding genes or by differential expression, the identification of MR proteins by conventional methods is challenging...
February 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/28127048/cell-cycle-proteins-as-promising-targets-in-cancer-therapy
#9
REVIEW
Tobias Otto, Piotr Sicinski
Cancer is characterized by uncontrolled tumour cell proliferation resulting from aberrant activity of various cell cycle proteins. Therefore, cell cycle regulators are considered attractive targets in cancer therapy. Intriguingly, animal models demonstrate that some of these proteins are not essential for proliferation of non-transformed cells and development of most tissues. By contrast, many cancers are uniquely dependent on these proteins and hence are selectively sensitive to their inhibition. After decades of research on the physiological functions of cell cycle proteins and their relevance for cancer, this knowledge recently translated into the first approved cancer therapeutic targeting of a direct regulator of the cell cycle...
27, 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/28127047/oncogenes-coping-with-stress
#10
Sarah Seton-Rogers
No abstract text is available yet for this article.
January 27, 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/28127046/metastasis-the-fat-controller
#11
M Teresa Villanueva
No abstract text is available yet for this article.
January 27, 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/28127045/metastasis-planting-metastasis-early
#12
Gemma K Alderton
No abstract text is available yet for this article.
January 27, 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/28127044/tumour-metabolism-packed-full-of-protein
#13
Anna Dart
No abstract text is available yet for this article.
January 27, 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/27982039/lymphoma-now-you-see-it
#14
Safia Danovi
No abstract text is available yet for this article.
January 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/27932800/timps-versatile-extracellular-regulators-in-cancer
#15
Hartland W Jackson, Virginie Defamie, Paul Waterhouse, Rama Khokha
A compelling long-term goal of cancer biology is to understand the crucial players during tumorigenesis in order to develop new interventions. Here, we review how the four non-redundant tissue inhibitors of metalloproteinases (TIMPs) regulate the pericellular proteolysis of a vast range of matrix and cell surface proteins, generating simultaneous effects on tumour architecture and cell signalling. Experimental studies demonstrate the contribution of TIMPs to the majority of cancer hallmarks, and human cancers invariably show TIMP deregulation in the tumour or stroma...
January 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/27932799/immunotherapy-switching-off-immune-suppression
#16
Sarah Seton-Rogers
No abstract text is available yet for this article.
January 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/27909340/cell-migration-caged-for-protection
#17
Anna Dart
No abstract text is available yet for this article.
January 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/27909339/cancer-cell-motility-lessons-from-migration-in-confined-spaces
#18
REVIEW
Colin D Paul, Panagiotis Mistriotis, Konstantinos Konstantopoulos
Time-lapse, deep-tissue imaging made possible by advances in intravital microscopy has demonstrated the importance of tumour cell migration through confining tracks in vivo. These tracks may either be endogenous features of tissues or be created by tumour or tumour-associated cells. Importantly, migration mechanisms through confining microenvironments are not predicted by 2D migration assays. Engineered in vitro models have been used to delineate the mechanisms of cell motility through confining spaces encountered in vivo...
2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/27885265/the-disparate-origins-of-ovarian-cancers-pathogenesis-and-prevention-strategies
#19
Anthony N Karnezis, Kathleen R Cho, C Blake Gilks, Celeste Leigh Pearce, David G Huntsman
Ovarian cancer is the fifth cause of cancer-related death in women and comprises a histologically and genetically broad range of tumours, including those of epithelial, sex cord-stromal and germ cell origin. Recent evidence indicates that high-grade serous ovarian carcinoma, clear cell carcinoma and endometrioid carcinoma primarily arise from tissues that are not normally present in the ovary. These histogenetic pathways are informing risk-reduction strategies for the prevention of ovarian and ovary-associated cancers and have highlighted the importance of the seemingly unique ovarian microenvironment...
January 2017: Nature Reviews. Cancer
https://www.readbyqxmd.com/read/27885264/deciphering-the-divergent-roles-of-progestogens-in-breast-cancer
#20
Jason S Carroll, Theresa E Hickey, Gerard A Tarulli, Michael Williams, Wayne D Tilley
Most breast cancers are driven by oestrogen receptor-α. Anti-oestrogenic drugs are the standard treatment for these breast cancers; however, treatment resistance is common, necessitating new therapeutic strategies. Recent preclinical and historical clinical studies support the use of progestogens to activate the progesterone receptor (PR) in breast cancers. However, widespread controversy exists regarding the role of progestogens in this disease, hindering the clinical implementation of PR-targeted therapies...
January 2017: Nature Reviews. Cancer
journal
journal
39814
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"